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ABSTRACT
A mutant at the carboxyl end of the terminal protein, p3, of
phage $29 DNA has been constructed by inserting an oligonucleo-
tide containing the stop translation codon TGA in the three
possible reading frames, immediately downstream of a 029 DNA
fragment coding for all but the last five amino acids of protein
p3. The activity in the formation of the p3-dAMP initiation com-
plex in vitro of this mutant as well as another one previously
isolated, also mutated at the carboxyl end, have been tested.
The results obtained suggest that an intact carboxyl end in the
029 terminal protein is essential for its normal primer function
in DNA replication.
INTRODUCTION
The Bacillus subtilis phage $29 has a linear, double-stranded
DNA 18,000 base pairs long (1) with a viral protein, p3, cova-
lently bound to the two 5' ends (2-5). 029 DNA replication starts
at either end of the DNA molecule and proceeds by strand displa-
cement (6-8). Protein p3 is the product of gene 3, shown to be
involved in the initiation of the viral DNA replication in vivo
(9). The terminal protein, p3, primes the initiation of 029 DNA
replication in vitro, by formation of a p3-dAMP covalent complex
that provides the 3' OH group needed for elongation. The reactin
also requires $29 DNA-protein p3 as template (10,11) and the pre-
sence of the product of gene 2 (12), which has been previously
shown to be also involved in the initiation of $29 DNA replica-
tion in vivo (9).
The region of the viral genome containing gene 3 has been
placed under the control of the bacteriophage X thermdinducible
pL promoter contained in the plasmid pPLc28 (13) allowing in this
way the overproduction of a protein p3 modified at its carboxyl
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end, p3', with the last four amino acids of the normal protein
replaced by eight new ones (14). We report in this paper the
construction and overproduction in a similar manner of a new p3
mutant at the carboxyl end, p3", having the length of the normal
polypeptide but the last three amino acids changed. We have used
both mutant proteins, p3' and p3", to study the initiation of
$29 DNA replication in vitro, the activity being 15% and 12%,
respectively, from that found with the normal protein p3. These
results suggest the requirement of a non-altered carboxyl end
for the protein p3 to be fully functional.
MATERIALS AND METHODS
Bacterial strains and plasmids
The E. coli strain HB101 (15) was obtained from N.E. Murray.
E. coli K12AH1Atrp (16) has been described elsewhere (13). Plas-
mid pKTH601 (17) was obtained from R.F. Pettersson and used as a
cloning vector as well as plasmid pPLc28 (13) which was obtained
from E. Remaut. Plasmids pKC30 Al and pKC30 B1 (18) were obtained
from J.A. Garcia. Plasmid pRMw5l has been described before (14).
Enzymes
Restriction enzymes were from New England Biolabs and used
according to the supplier. T4 DNA ligase was purified by J.M.
Lazaro from E. coli cells harbouring the plasmid pPLc28 ligase 8
obtained from E. Remaut. Fungal proteinase K was from Merck and
micrococcal nuclease from Worthington.
DNA preparations
The $29 DNA-protein p3 complex (10) and proteinase K-treated
$29 DNA (19) were obtained as described. Extracts from B. subti-
lis infected with the $29 mutant sus3(91) (20) were obtained
from J.A. Garcia. Plasmid DNA was prepared according to Clewell
(21). The $29 DNA Hind III G fragment purification, ligation,
transformation, antibiotic selection of recombinants, DNA mini-
preparations and agarose gel electrophoresis were as described
(14).
Characterization of the protein p3 mutants
The polypeptides synthesized upon induction of E. coli
K12AHlAtrp harbouring the recombinant plasmids were radioactive-
ly labelled with 35S-methionine and analysed by 20% polyacryl-
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amide electrophoresis in the presence of SDS followed by auto-
radiography (14). The relative production of the mutant proteins
was determined by densitometry of the autoradiographs and ex-
pressed as percentage of the total labelled protein in the gel
lane (14).
E. coli cultures transformed with the recombinant plasmids
were induced and lysed as described (18). The presence of the
mutant polypeptides in the extracts was tested by a binding ra-
dioimmunoassay (22) modified as it will be described elsewhere
(23). Basically the protein in the extracts was bound to the
wells of a polystyrene plate and then incubated with rabbit an-
ti-p3 serum (a gift from I. Prieto) followed, after washing, by
incubation with { 125I-protein A. The radioactivity bound was
removed with 2 M NaOH and counted.
Assay for the in vitro formation of protein p3-dAMP initiation
complex
Cell cultures carrying the recombinant plasmids were grown
in L broth, induced at 420C for 3 hr, and the cells were collec-
ted, washed, ground with twice their weight of alumina, centri-
fuged at low-speed to remove bacterial debris, and passed through
a Sephadex G-50 column to eliminate endogenous nucleotides, as
described (18). The incubation mixture for the initiation react-
ion was as described by Pefialva and Salas (10) and contained, in
a final volume of 0.05 ml, 50 mM Tris-HCl, pH 7.5, 10 mM MgCl2,
1 mM ATP,0.25 ~uM fc-32P}dATP (5 pCi), 35 )ig of protein from ex-
tracts from sus3 infected B. subtilis prepared as described (11),
5-45 pg of protein from extracts of E. coli harbouring the re-
combinant plasmids as source of protein p3, prepared as descri-
bed (18) and about 0.6 pg of 929 DNA-protein p3 as template. Af-
ter 20 min at 300C the samples were processed and the p3-dAMP
complexes formed analyzed by 10% polyacrylamide gel electropho-
resis in the presence of SDS as described (10). The gels were
dried and autoradiographed with intensifying screens at -700C.
The amount of p3-dAMP complex formed was quantitated by densito-
metry of the autoradiographs. Several doses of the different
sources of protein p3 were assayed to obtain a linear response
in the amount of p3-dAMP formed.
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RESULTS AND DISCUSSION
Construction of recombinant Dlasmids
The fragment Hind III G of 029 DNA contains the information
for the synthesis of protein p3 except for the last five amino
acids at the carboxyl end (24,25). The plasmid pKTH601 (17) con-
tains the synthetic oligonucleotide TGATTGATTGA flanked by Hind
III and Bam HI targets replacing the natural Hind III-Bam HI
fragment of pBR322 so that any sequence inserted at the Hind III
site of pKTH601 will be followed downstream by the translation
stop codon TGA in any of the three nossible reading frames. Thus,
the cloning of the 029 DNA Hind III G fragment in DKTH601 will
ensure that translation termination occurs shortly after the in-
serted viral sequences. In fact, a mutant protein p3 (p3") could
be synthesized that would have the same length as the normal
protein p3 but containina three different amino acids at the
carboxyl end. The construction of such a recombinant (pRMtl2) is
shown in Figure 1.
The Eco RI-Bam HI fragment from pRMtl2,containing the 029
DNA sequences cloned in the appropriate orientation (Fig. 1),was
transferred to the plasmid pPLc28 (13) previously cut with Eco
RI and Bam HI together, so that the viral sequences were under
the direct control of the X PL promoter. The Dlasmid pRMtl2 was
also cut with Pst I to avoid the cloning of any other fragment
but the desired one. The recombinant plasmid pRMtl21, obtained
in this manner is shown in Figure 1.
The plasmid pRMw5l has been described before (14) and was
constructed in a similar way as pRMtl21, but pBR322 (26) was
used instead pKTH601, so that the protein p3 encoded in pRMw51,
named p3', is 4 amino acids longer than the normal one and dif-
fers from it in a total of eight amino acids at the carboxyl end
of the molecule (14).
Plasmids pKC30 Al and pKC30 BI (18) contain the 029 DNA se-
quences coding for a normal protein p3 under the control of the
phage X PL promoter harboured in the plasmid pKC30 (27). The
plasmid pKC30 Al carries the viral DNA sequences inserted in the
correct orientation, whereas pKC30 B1 carries them in the oDDo-
site one, so that upon induction of the PL promoter a normal
protein p3 is synthesized only in the cell cultures containing
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Fig.l. Construction of recombinant plasmid pRMtl2l. The arrows
above genes 3 and 4 indicate their extension and direction of
transcription in 029 DNA with respect to the PL promoter in
pRMtl21. The direction of transcription of the ampicillin resis-
tance gene is also indicated.
the plasmid pKC30 Al (18). Both the pKC30 and the pPLc28 deriva-
tive plasmids were propagated in the lysogen E. coli K12AHlAtrp
so that the transcription from the PL promoter will be repressed
at 30 0C by the thermosensitive cI857 repressor carried by the
lysogen host, being the normal transcription from PL fully res-
tored upon heat induction (13).
Inducible synthesis of the 929 proteins coded by pRMtl2l
Bacteria carrying the plasmid pRMtl21 were grown as descri-
bed (14). After 1 hr at 300C one half of the culture was shifted
to 420C and at 90 and 180 min after induction, samples from the
42°C culture were labelled with 35S-methionine for 10 min. As a
control, samples from the cultures kept at 30°C were equally la-
belled. Expression of the recombinant plasmid produced, in addi-
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Fig921 Induced synthesis of protein p3" directed by plasmid
pRMtlEIl. Bacterial cu tures harbouring the plasmid pRMtl2l were
grown,r labelled with S-methionine and subjected to SDS-poly-
acrylamide gel electrophoresis as described in Materials and Me-
thods. The starting time of each labelling period (in min) an~
the temperature of incubation are indicated above the lanes. 3H-
concanavalin A peptides (The Radiochemical Centre, Amersham) of
known molecular weights (29) were used as markers. The molecular
weight of the markers in K daltons is given at the right, as well
as the position of proteins p3", p4 and a 14.5 K induced poly-
peptide.
tion to protein p4 (14) , a protein with the electrophoretic mo-
bility expected for the newly constructed protein p3"' (Fig. 2).
Both proteins were missing in the cultures kept at 300C. A new
polypeptide with a molecular weight of 14,500 was also labelled
in the induced cultures and corresponds to the fusion of pKTH6O1
sequences contained in the cloned Eco RI-Ban HI fragment with
7402
Nucleic Acids Research
0 £ tz __
-pRMw5l
E
.2
c' * *--1- * pKC 30 Al
Ui __o 1j--- pKC30Bl
0.5 1.0 2.0 4.0
Protein, pg
Fig.3. Radioimmunoassay of protein p3 in extracts from cells
carrying the recombinant plasmids. The assay was carried out as
described in Materials and Methods by addition of increasing
amounts of the extracts to a polystyrene multiwell plate follow-
ed by incubation, first with anti-p3 serum and then with {125I}-
protein A. The radioactivity bound to each well was counted.
those of plasmid pPLc28 (13,17,28). The level of the mutant
protein p3" synthesized under these conditions reached about 9%
of de novo made protein at both 90 and 180 min after induction.
The electrophoretic mobility of protein p3" coincides with that
of normal protein p3 (results not shown).
Characterization of the p3 mutants
To asses that the extracts prepared from cells transformed
by the recombinant plasmids contained the p3 mutants, a radio-
immunoassay with anti p3-serum was carried out. Fig. 3 shows that
{125I}-protein A was specifically bound in the case of cell ex-
tracts containing either plasmid pRMw5l, which directs the syn-
thesis of protein p3', or plasmid pRMtl2l which codes for prot-
ein p3". {125I}-protein A was also bound when cell extracts
carrying the plasmid pKC30 Al, which produces a normal p3, were
used whereas in the case of the plasmid pKC30 Bi, which does not
produce p3, very little binding of { I25I-protein A was detected.
The difference in the amount of radioactivity bound in each
case (see Table 1) correlates reasonably well with the differen-
ce in the level of synthesis upon induction of the normal and
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Table 1. Effect of the mutations of protein p3 on the formation
of the initiation complex
Plasmid protein activity,%a ratiob corrected activity, %c
pKC30 A1 p3 100 1.0 100
pRMw5l p3' 32 2.1 15
pRMtl2l p3" 45 3.7 12
Extracts from E. coli harbouring the different recombinant plas-
mids were prepared as described in Materials and Methods. The
activity of the normal and the mutated p3 proteins in the forma-
tion of the p3-dAMP initiation complex was tested in the in vi-
tro system.
aPercentage of the activity (referred to total protein) in the
formation of p3-dAMP as determined by densitometrv of the auto-
radiographs. The values given are average from 2 experiments
done with different sets of extracts.
bRatio of relative p3 present in the extracts as determined by
radioimmunoassay. Values are average from 2 exDeriments done
with different sets of extracts.
cActivity corrected for the relative amount of D3 protein pre-
sent in the different extracts.
mutated p3 proteins. Normal protein p3 is produced in approxima-
tely 3% of the total de novo protein made (results not shown,18)
and proteins p3' and p3" account for about 6% (14) and 9%, res-
pectively. Therefore, the amount of synthesis of protein p3'
and p3" is roughly 2 and 3 times more than that of protein p3.
Activity of the protein p3 mutants in the formation of the
initiation complex p3-dAMP
Extracts from E. coli transformed with the recombinant plas-
mids pKC30 Al, pRMw5l and pRMtl2l, which produce the normal pro-
tein p3 and the mutant proteins p3' and p3", respectively, were
tested for the formation in vitro of the p3-dAMP complex in a
complementation assay using extracts from B. subtilis infected
with a 029 sus mutant in gene 3. Figure 4 shows that in the pre-
sence of 029 DNA-protein p3 as template, the addition of any of
the three extracts results in the labelling of the corresponding
protein p3 with {a-32P}dATP, that is in the formation of the p3-
dAMP initiation complex. The reaction was dependent on $29 DNA-
protein p3 since proteinase K-treated 029 DNA did not act as
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pKC3OAI pRMw5l pRMt121 35S-029
84 K
-70 K
_- 52 K
-48 K
-40 K
____-275K
p3
pKC30AI ..ser-leu-Iys-gly-phe
pRM w 51 ser-phe-osn-alo-val-val-tyr-his-ser
pRMt 121 ..ser-leu-leu-ile-asp
Fig. 4. Synthesis of the p3-dAMP complex in.vitro. Extracts from
E. coli Kl2AHlAtrp containing the recombinant plasmids indicated
above the lanes were prepared as described in Materials and Me-
thods. E. coli extracts from cells containing the recombinant
plasmids (v l pg) were added to the incubation mixture as indi-
cated in Materials and Methods. The p3-dAMP complexes formed were
analyzed by polyacrylamide gel electrophoresis. The lower part of
the figure shows the predicted amino acid sequence at the carbo-
xyl end of the normal p3 (pKC30 Al) and mutated p3' (pRMw5l) and
p3" (pRMtl2l) polypeptides.
template (results not shown). Densitometry of the 32P-labelled
p3 in each case showed that the amount of p3-dAMP complex formed
by the extracts containing plasmids pRMw5l and pRMtl2l was appro-
ximately 32% and 45% of that formed by the extracts containing
the plasmid pKC30 Al (Table 1). These values have to be corrected
by the relative level of production of the different p3 polypep-
tides as estimated by the radioimmunoassay with anti-p3 serum.
Table 1 shows that when this correction is made, the activity of
the mutant proteins p3' and p3" goes down to about 15% and 12%,
respectively, from that of the normal protein p3. The lower part
of Figure 4 shows the predicted amino acid sequence at the carbo-
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xyl end of the normal protein p3 (pKC30 Al) and of the mutant
proteins p3' (pRMw5l) and p3" (pRMtl2l), being the rest of the
peptide sequences the same for the three proteins. The fact that
the modification at the protein p3 carboxyl end in the two mu-
tants affects largely the activity of the protein, strongly sug-
gests that an intact carboxyl end is needed for the full func-
tion of protein p3. It is known that the linkage of protein p3
to 029 DNA occurs through a phosphoester bond between the OH
group of a serine residue and 5'-dAMP, the terminal nucleotide
at both 5' ends (30). If any of the serine resudues Present at
the carboxyl end of the p3 molecule were responsible for the co-
valent linkage to dAMP, then any modification of the region next
to these residues might influence the protein activity, as it is
the case when the change of a lys-gly-phe residue for a leu-ile-
asp has been made in protein p3" or when, in addition to the
change of the four carboxy terminal amino acids Dresent in the
normal protein, four extra amino acids have been added (protein
p3'). Alternatively, the carboxyl end of protein p3 could be ei-
ther forming part of an active center in the molecule or being
absolutely required to built up an stable conformation of the
protein.
A way to produce and select for short deletion mutants at
the carboxyl end of protein p3 is currently being developed to
determine how essential is the carboxyl end for the function of
protein p3 in the initiation of 029 DNA replication.
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